BioSpace News Archive

Linshom announced U.S. Food and Drug Administration 510 clearance of the company’s first product, a small, non-invasive respiratory monitor that addresses the growing need for continuous respiratory monitoring for patients susceptible to respiratory depression and compromise.

Vectura Group plc announces a key appointment to support innovation, customer focus and growth as the company continues with its strategic development as a leading inhalation specialist in the pharmaceutical services space.

When used by adults every four days, ESPEROCT® can help reduce the frequency of bleeding with less frequent dosing

DIAN-TU-001 is a Phase II/III trial that tested two therapies compared to placebo, Genentech and Roche’s gantenerumab and Eli Lilly and Company’s solanezumab.

More than five million women suffer from symptoms of uterine fibroids, with more than half of them estimated to have received inadequate treatment. However, new data released by Myovant shows that concerns of inadequate treatment could soon change.

“The FDA filing acceptance for Libervant is an important milestone in our mission to provide epilepsy patients with a broader array of treatment options, that represent major contributions to patient care,” said Keith J. Kendall, Aquestive’s chief executive officer.

A clearer picture of how DNA changes lead to cancer has emerged, following the most comprehensive evaluation of non-coding driver mutations to date by researchers at the Wellcome Sanger Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, Aarhus University Hospital and their collaborators.

Biotechnology company, Cellexus International Ltd, have added a new product to their range of patented CellMaker single-use airlift bioreactor systems.

This partnership with the AP-HM could lead to a world first and opens up important applications in the field of regenerative medicine.

TreeFrog Therapeutics, a pure player in iPSC-derived cell therapies, announces the appointment of 2 senior executives and 2 independent board members.